141 related articles for article (PubMed ID: 33096236)
1. Δ
Rowton SS; Rocha BA; Porter IE
J Pharmacol Toxicol Methods; 2020; 106():106937. PubMed ID: 33096236
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.
Lefever TW; Marusich JA; Antonazzo KR; Wiley JL
Pharmacol Biochem Behav; 2014 Mar; 118():30-5. PubMed ID: 24412835
[TBL] [Abstract][Full Text] [Related]
3. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
Stewart JL; McMahon LR
J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the discriminative stimulus and response rate effects of
Wiley JL; Lefever TW; Marusich JA; Craft RM
Drug Alcohol Depend; 2017 Mar; 172():51-59. PubMed ID: 28130989
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
McMahon LR; Ginsburg BC; Lamb RJ
Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
[TBL] [Abstract][Full Text] [Related]
6. Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.
Gatch MB; Forster MJ
Behav Pharmacol; 2014 Dec; 25(8):750-7. PubMed ID: 25325289
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.
Marshell R; Kearney-Ramos T; Brents LK; Hyatt WS; Tai S; Prather PL; Fantegrossi WE
Pharmacol Biochem Behav; 2014 Sep; 124():40-7. PubMed ID: 24857780
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys.
Delatte MS; Paronis CA
Psychopharmacology (Berl); 2008 Jul; 198(4):521-8. PubMed ID: 17882403
[TBL] [Abstract][Full Text] [Related]
10. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
Wiley JL; Lefever TW; Cortes RA; Marusich JA
Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
[TBL] [Abstract][Full Text] [Related]
11. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol.
Järbe TU; Li C; Vadivel SK; Makriyannis A
Psychopharmacology (Berl); 2010 Jan; 208(1):87-98. PubMed ID: 19902182
[TBL] [Abstract][Full Text] [Related]
13. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.
Gatch MB; Forster MJ
Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
15. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.
Brents LK; Zimmerman SM; Saffell AR; Prather PL; Fantegrossi WE
J Pharmacol Exp Ther; 2013 Sep; 346(3):350-61. PubMed ID: 23801678
[TBL] [Abstract][Full Text] [Related]
16. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
[TBL] [Abstract][Full Text] [Related]
17. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates.
Cooper ZD; Evans SM; Foltin RW
Exp Clin Psychopharmacol; 2021 Apr; 29(2):137-146. PubMed ID: 34043398
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.
Järbe TU; LeMay BJ; Halikhedkar A; Wood J; Vadivel SK; Zvonok A; Makriyannis A
Psychopharmacology (Berl); 2014 Feb; 231(3):489-500. PubMed ID: 24005529
[TBL] [Abstract][Full Text] [Related]
19. Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.
Winsauer PJ; Filipeanu CM; Bailey EM; Hulst JL; Sutton JL
Pharmacol Biochem Behav; 2012 Sep; 102(3):442-9. PubMed ID: 22705493
[TBL] [Abstract][Full Text] [Related]
20. [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].
Tomiyama K; Funada M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Jun; 47(3):135-43. PubMed ID: 22894054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]